MIA:


  • WHO ATC First Level (Anatomical main group) ID: J ANTIINFECTIVES FOR SYSTEMIC USE
  • WHO ATC Second Level (Therapeutic subgroup) ID: J04 ANTIMYCOBACTERIALS
  • WHO ATC Third Level (Pharmacological subgroup) ID: J04B DRUGS FOR TREATMENT OF LEPRA
  • WHO ATC Fourth Level (Chemical subgroup) ID: J04BA Drugs for treatment of lepra
  • WHO ATC Fifth Level (Chemical substance) ID: J04BA01 Clofazimine

  • Chemical Name: Clofazimine
  • Chemical Smi: Clc1ccc(cc1)Nc1cc2nc3ccccc3n(c2c/c/1=N\\C(C)C)c1ccc(cc1)Cl

  • WHO ICD Mapped Level : A30.5 A30.5 Name: Lepromatous leprosy
  • WHO ICD Fourth Level ID: A30.5 A30.5 Name: Lepromatous leprosy
  • WHO ICD Third Level ID: A30 A30 Name: Leprosy [Hansen disease]
  • WHO ICD Second Level ID: A30-A49 A30-A49 Name: Other bacterial diseases
  • WHO ICD First Level ID: I I Name: Certain infectious and parasitic diseases